The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Allogeneic stem cell transplantation (AlloSCT) for patients (pts) with lymphoma and chronic lymphocytic leukemia (CLL) following targeted small molecules inhibitors (SMIs).
 
Akash Mukherjee
No Relationships to Disclose
 
Denai R. Milton
No Relationships to Disclose
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Pfizer; Takeda
 
Alison Gulbis
No Relationships to Disclose
 
Tapan M. Kadia
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Celgene; Sanofi
 
Philip A. Thompson
No Relationships to Disclose
 
Michael J. Keating
No Relationships to Disclose
 
Nitin Jain
Honoraria - Adaptive Biotechnologies; ADC Therapeutics; Novartis; Novimmune; Pfizer; Pharmacyclics; SERVIER
Consulting or Advisory Role - Adaptive Biotechnologies; ADC Therapeutics; Novartis; Novimmune; Pfizer; Pharmacyclics; SERVIER
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Pfizer (Inst); Pharmacyclics (Inst); Seagen (Inst); SERVIER (Inst)
 
Celina Ledesma
No Relationships to Disclose
 
Luis Fayad
No Relationships to Disclose
 
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Spectrum Pharmaceuticals
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
 
Jan Andreas Burger
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Pharmacyclics; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Alessandra Ferrajoli
Patents, Royalties, Other Intellectual Property - Acerta Pharma; Celgene; Genentech
 
Zeev Estrov
No Relationships to Disclose
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Richard E. Champlin
No Relationships to Disclose
 
Issa F. Khouri
No Relationships to Disclose